| Tue, 18 Feb 2020 17:57:05: | Five Prime Therapeutics’ pancreatic cancer combo with Opdivo a bust
|
| Tue, 18 Feb 2020 13:50:05: | Crossover round, check. New team of biopharma execs, check. Now, Imara wants an IPO
|
| Tue, 18 Feb 2020 13:37:59: | PharmaMar, Jazz get FDA priority review for lung cancer drug
|
| Tue, 18 Feb 2020 13:21:14: | Gene therapy tackles tau tangles in mouse models of dementia
|
| Tue, 18 Feb 2020 12:59:49: | Vifor buys priority review voucher for vadadustat filing
|
| Tue, 18 Feb 2020 12:47:46: | After $105M funding round, ALX Oncology nabs FDA fast-track tag for cancer hopeful
|
| Fri, 14 Feb 2020 13:58:08: | Novimmune unit nabs Takeda milestone payment for hemophilia work
|
| Fri, 14 Feb 2020 13:40:09: | China's CICC Capital raises $229M biologic investment fund
|
| Fri, 14 Feb 2020 12:26:31: | Targeting the 'clock gene' in obesity to slow triple-negative breast cancer
|
| Fri, 14 Feb 2020 10:42:44: | Melinta seeks buyout bids to secure escape from bankruptcy
|
| Fri, 14 Feb 2020 08:55:52: | AstraZeneca cans cancer pipeline efforts
|
| Thu, 13 Feb 2020 20:35:27: | Chutes & Ladders—Ex-Pfizer R&D head Abraham joins Vividion
|
| Thu, 13 Feb 2020 13:17:47: | Bristol-Myers' CAR-T gets priority review, mid-August PDUFA date
|
| Thu, 13 Feb 2020 12:46:39: | Ipsen takes €669M hit as palovarotene's prospects wither
|
| Thu, 13 Feb 2020 12:46:34: | How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
|
| Thu, 13 Feb 2020 10:29:44: | Deciphera nabs speedy review for GIST cancer hopeful
|
| Thu, 13 Feb 2020 09:40:29: | CROs, clinical researchers brace for impact of coronavirus shutdown across China
|
| Wed, 12 Feb 2020 14:46:25: | Ligand snags Roche-partnered drug in Icagen buyout
|
| Wed, 12 Feb 2020 14:04:39: | J&J allies with BARDA to accelerate coronavirus vaccine program
|
| Wed, 12 Feb 2020 12:45:53: | ALX raises $105M for midphase trials of CD47 cancer drug
|
| Wed, 12 Feb 2020 12:24:08: | Attacking pancreatic cancer with the help of the virus that causes foot-and-mouth disease in cows
|
| Tue, 11 Feb 2020 13:59:00: | Trump tries again to reduce NIH budget, spares FDA from cuts
|
| Tue, 11 Feb 2020 13:31:13: | Ex-Pfizer oncology R&D lead lands at Fierce 15 winner Vividion Therapeutics
|
| Tue, 11 Feb 2020 12:56:35: | LogicBio rocked by FDA clinical hold on genome editing trial
|
| Tue, 11 Feb 2020 09:19:48: | Trial flops see Pfizer cut GlycoMimetics pact, Merck ax KalVista research deal
|
